Terminated NA INTERVENTIONAL 2-arm NCT06450522

Post-Discharge Pharmacist-led Rapid Medication Optimization for Heart Failure (Post-Discharge PHARM-HF)

Post-Discharge Pharmacist-led Rapid Medication Optimization for Heart Failure (Post-Discharge PHARM-HF): a Randomized Controlled Trial

Sponsor: University of British Columbia

Conditions Heart Failure with Reduced Ejection Fraction HFrEF

Interventions Pharmacist co-management of HF medication optimization Usual care

Updated 5 times since 2024 Last updated: Feb 21, 2025 Started: Jul 4, 2024 Primary completion: Feb 21, 2025 Completion: Feb 21, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Slow recruitment

Other terminated trials from University of British Columbia

See all terminations from University of British Columbia

This NA trial investigates Heart Failure with Reduced Ejection Fraction HFrEF and is currently terminated or withdrawn. University of British Columbia leads this study, which shows 5 recorded versions since 2024 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Mar 2025 — Present [monthly]

Terminated NA

Status: Recruiting → Terminated
Nov 2024 — Mar 2025 [monthly]

Recruiting NA
Sep 2024 — Nov 2024 [monthly]

Recruiting NA
Aug 2024 — Sep 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jul 2024 — Aug 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of British Columbia

Data source: University of British Columbia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vancouver, Canada